Company Filing History:
Years Active: 2020
Title: The Innovative Contributions of Dongyao Yan
Introduction
Dongyao Yan is a prominent inventor based in Rockville, MD (US). He has made significant contributions to the field of cancer treatment through his innovative research and patented methods. With a total of 2 patents, Yan's work focuses on improving therapeutic strategies for cancer patients.
Latest Patents
One of Yan's latest patents involves the expression of OPRT and its implications for cancer treatment outcomes. This patent provides improved methods for determining whether a cancer patient, particularly those with colon or gastric cancer, will respond favorably to the FOLFOX regimen or a combination of capecitabine and cisplatin. The diagnostic methods outlined in this patent include measuring the OPRT, TYMP, and/or UCK2 proteins in tissue samples from patients.
Another significant patent by Yan focuses on quantifying the MGMT protein for optimal therapy in glioblastoma patients. This method involves administering an effective amount of temozolomide to patients suffering from glioblastoma, based on mass spectrometry analysis of a protein digest from a formalin-fixed tumor sample. The analysis evidences an amount of a MGMT fragment peptide less than or substantially equal to 150 amol/μg.
Career Highlights
Dongyao Yan is currently associated with Nantomics, LLC, where he continues to advance his research in cancer treatment. His work has garnered attention for its potential to significantly improve patient outcomes in oncology.
Collaborations
Yan collaborates with notable colleagues, including Todd Hembrough and Fabiola Cecchi, who contribute to his research endeavors and enhance the impact of his innovations.
Conclusion
Dongyao Yan's contributions to cancer treatment through his patented methods demonstrate his commitment to improving patient care. His innovative approaches have the potential to change the landscape of cancer therapy, making him a noteworthy figure in the field of medical research.